Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients

Ramona Cassin; Andrea Visentin; Diana Giannarelli; Alessandro Noto; Francesca Romana Mauro; Luca Baldini; Livio Trentin; Gianluigi Reda

doi:10.1002/hon.2814

Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients

Ramona Cassin, Andrea Visentin, Diana Giannarelli, Alessandro Noto, Francesca Romana Mauro, Luca Baldini, Livio Trentin, Gianluigi Reda

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Hematological Oncology
DOIs	https://doi.org/10.1002/hon.2814
Publication status	E-pub ahead of print - Oct 9 2020

Access to Document

10.1002/hon.2814

Cite this

Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients. / Cassin, Ramona; Visentin, Andrea; Giannarelli, Diana; Noto, Alessandro; Mauro, Francesca Romana; Baldini, Luca; Trentin, Livio; Reda, Gianluigi.

In: Hematological Oncology, 09.10.2020.

Research output: Contribution to journal › Article › peer-review

@article{22ed32188d624639a97e37c498676bf5,

title = "Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients",

author = "Ramona Cassin and Andrea Visentin and Diana Giannarelli and Alessandro Noto and Mauro, {Francesca Romana} and Luca Baldini and Livio Trentin and Gianluigi Reda",

year = "2020",

month = oct,

day = "9",

doi = "10.1002/hon.2814",

language = "English",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "wiley",

}

TY - JOUR

T1 - Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients

AU - Cassin, Ramona

AU - Visentin, Andrea

AU - Giannarelli, Diana

AU - Noto, Alessandro

AU - Mauro, Francesca Romana

AU - Baldini, Luca

AU - Trentin, Livio

AU - Reda, Gianluigi

PY - 2020/10/9

Y1 - 2020/10/9

U2 - 10.1002/hon.2814

DO - 10.1002/hon.2814

M3 - Article

C2 - 33034902

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

ER -